Eyenovia, Inc. (NASDAQ:EYEN) Q4 2021 Earnings Conference Call March 28, 2022 4:30 PM ET Company Participants Eric Ribner - Investor Relations Sean Ianchulev - Chairman, Chief Executive Officer and Chief Medical Officer Michael Rowe - Chief Operating Officer John Gandolfo - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Tim Chiang - Northland Securities Len Yaffe - Stoc*Doc Partners Operator Greetings. Welcome to the Eyenovia Fourth Quarter and Full Year 2021 Earnings C ...

Eyenovia, Inc. (NASDAQ:EYEN) Q3 2021 Earnings Conference Call November 11, 2021 5:00 PM ET Company Participants Eric Ribner - Investor Relations Dr. Sean Ianchulev - Chief Executive officer and CMO Michael Rowe - Chief Operating Officer John Gandolfo - Chief Financial Officer Conference Call Participants Tim Chiang - Northland Capital Matt Kaplan - Ladenburg Thalmann Len Yaffe - Stoc*Doc Partners Operator Greetings. Welcome to Eyenovia’s Third Quarter 2021 Earnings Call. At this time, all participants are i ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. (Exact name of Registrant as Specified in Its Charter) | --- | |-------------------------------- ...

Eyenovia, Inc. (NASDAQ:EYEN) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Eric Ribner – Investor Relations Michael Rowe – Chief Operating Officer John Gandolfo – Chief Financial Officer Conference Call Participants Tim Chiang – Northland Capital Matt Kaplan – Ladenburg Thalmann Len Yaffe – Stoc*Doc Partners Operator Thank you for standing by. This is the conference operator. Welcome to the Eyenovia's Second Quarter 2021 Earnings Call. As a reminder all participants are in ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. (Exact name of Registrant as Specified in Its Charter) | --- | |------------------------------------- ...

Making it Possible May 2021 Forward-Looking Statements 1 Except for historical information, all of the statements, expectations and assumptions contained in this presentation are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions, including estimated market opportunities for our product candi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 Par Value EYEN Nasdaq Capital Market FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to __________ ...

Eyenovia, Inc. (NASDAQ:EYEN) Q1 2021 Earnings Conference Call May 12, 2021 4:30 PM ET Company Participants Eric Ribner – Investor Relations Sean Ianchulev – Chief Executive Officer and Chief Medical Officer Michael Rowe – Chief Operating Officer John Gandolfo – Chief Financial Officer Conference Call Participants Len Yaffe – Stoc*Doc Partners Tim Chiang – Northland Matt Kaplan – Ladenburg Thalmann Operator Greetings, welcome to Eyenovia's First Quarter 2021 Earnings Call. At this time, all participants are ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 | --- | --- | |---------------------------------------------------------------------------------- ...

Eyenovia, Inc. (NASDAQ:EYEN) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Eric Ribner – Investor Relations Sean Ianchulev – Chief Executive Officer and Chief Medical Officer Michael Rowe – Chief Operating Officer John Gandolfo – Chief Financial Officer Conference Call Participants Matt Kaplan – Ladenburg Jonathan Aschoff – ROTH Capital Partners Leonard Yaffe – Stoc*Doc Partners Matt Kaplan – Ladenburg Operator Greetings, welcome to Eyenovia's Fourth Quarter and Full Year 2 ...